BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProxsysRx, a healthcare solutions company, announced that it has received a significant growth equity investment from Atlanta-based Fulcrum Equity Partners with participation from members of the management team.
The funding will accelerate the company’s technological developments, expand the footprint of the organization to new markets around the United States, and provide additional infrastructure to support a larger company. The transaction was orchestrated by Nashville based investment banking firm Harpeth Capital. Fulcrum Partners Tom Greer and Jeff Muir lead the funding round; both have extensive backgrounds in growing healthcare services and IT businesses, and both will join the company’s Board of Directors.
ProxsysRx provides hospital and health system partners with technology-driven value, revenue, and savings through innovative administrative systems and pharmacy programs that increase patient engagement to achieve positive health outcomes. The ProxsysRx executive team has more than one hundred years of combined healthcare industry experience.
“The Fulcrum Equity Partners investment will further amplify our positive growth trajectory and provide additional expertise which will help guide the direction of our expansion. We are excited about this new relationship and look forward to working closely with Fulcrum as we expand the company footprint and continue our trend of offering our health system partners new services that will benefit both their patients and the health system itself,” said ProxsysRx CEO George B. Salem. Salem notes that the majority of ProxsysRx partners are regional medical centers that stand to benefit from improved performance and patient care which are so vital in these challenging times.
“We are excited about teaming with ProxsysRx in helping healthcare systems tackle challenging issues while improving health outcomes for patients. ProxsysRx benefits to partner healthcare systems are measurable and sustainable. Our investment in ProxsysRx will help the company accelerate its already impressive growth,” said Fulcrum partner Tom Greer who leads the investment team. Greer pointed out that ProxsysRx aligns perfectly with the Fulcrum Equity Partners investment model that supports rapidly growing companies that have proven entrepreneurial leadership and management in the healthcare and technology sectors.
ProxsysRx is a healthcare solutions company providing value, revenue, and savings to hospital and health system partners through inpatient and outpatient engagement and comprehensive pharmacy programs. Benefits to ProxsysRx partners include readmission risk reduction, 340B savings, employee benefit cost savings, and improved patient satisfaction. ProxsysRx services for hospitals and health care systems include onsite retail pharmacy, 340B administration, personalized and digital patient engagement and management, and employee health benefit program management.
About Fulcrum Equity Partners
Fulcrum Equity Partners is an Atlanta-based growth equity firm that manages over $500 million and provides expansion capital to rapidly growing companies led by strong entrepreneurs and management teams. Fulcrum targets companies within healthcare services, healthcare IT, B2B software, and technology-enabled services. Fulcrum’s initial target investment is $3 million - $15 million to provide financing to meet a wide range of needs, including internal growth initiatives, acquisitions, divestitures, shareholder liquidity and recapitalizations. The partners have over 140 years of relevant experience in Fulcrum’s target markets, including significant operating experience in senior executive positions at companies that grew rapidly and enjoyed successful exits. Additionally, Fulcrum’s limited partners include over 100 current or former business owners/CEOs of leading companies in a wide variety of industries that provide a rich resource for the firm and portfolio companies. Learn more at http://www.fulcrumep.com.